(Q46867675)

26 December 2017

title

A-102395, a new inhibitor of bacterial translocase I, produced by Amycolatopsis sp. SANK 60206. (English)

1 reference

26 December 2017

2-[3-[[3-[4-[[2-[2-amino-1-[5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-3-methoxyoxolan-2-yl]-2-oxoethoxy]-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carbonyl]amino]phenyl]-2,3-dihydroxypropanoyl]amino]prop-2-enoylamino]acetic acid

1 reference

1 reference

inferred from

reverse claim

2-[[(E)-3-[[3-[4-[[2-[2-amino-1-[5-(2,4-dioxopyrimidin-1-yl)-4-hydroxy-3-methoxyoxolan-2-yl]-2-oxoethoxy]-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carbonyl]amino]phenyl]-2,3-dihydroxypropanoyl]amino]prop-2-enoyl]amino]acetic acid

1 reference

Ryo Murakami

1

1 reference

26 December 2017

Yoko Fujita

2

1 reference

26 December 2017

Masaaki Kizuka

3

1 reference

26 December 2017

Tomoka Kagawa

4

1 reference

26 December 2017

Yasunori Muramatsu

5

1 reference

26 December 2017

Shunichi Miyakoshi

6

1 reference

26 December 2017

Toshio Takatsu

7

1 reference

26 December 2017

Masatoshi Inukai

8

1 reference

26 December 2017

publication date

November 2007

1 reference

full work available at URL

16 September 2022

https://www.nature.com/articles/ja200788.pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.1038/ja.2007.88?email=unpaywall_01@example.com

published in

The Journal of Antibiotics

1 reference

26 December 2017

volume

60

1 reference

26 December 2017

issue

11

1 reference

26 December 2017

page(s)

690-695

1 reference

26 December 2017

https://api.unpaywall.org/v2/10.1038/ja.2007.88?email=unpaywall_01@example.com

1 reference

19 March 2024

access restriction status

open access

1 reference

inferred from online access status

exact match

https://scigraph.springernature.com/pub.10.1038/ja.2007.88

0 references

cites work

Modes of action of tunicamycin, liposidomycin B, and mureidomycin A: inhibition of phospho-N-acetylmuramyl-pentapeptide translocase from Escherichia coli.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2007.88

7 January 2021

Mureidomycins A-D, novel peptidylnucleoside antibiotics with spheroplast forming activity. I. Taxonomy, fermentation, isolation and physico-chemical properties.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2007.88

7 January 2021

Pacidamycins, a novel series of antibiotics with anti-Pseudomonas aeruginosa activity. I. Taxonomy of the producing organism and fermentation.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2007.88

7 January 2021

Napsamycins, new Pseudomonas active antibiotics of the mureidomycin family from Streptomyces sp. HIL Y-82,11372.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2007.88

7 January 2021

The structure of liposidomycin B, an inhibitor of bacterial peptidoglycan synthesis

1 reference

https://api.crossref.org/works/10.1038%2FJA.2007.88

7 January 2021

Tunicamycin, a new antibiotic. I. Isolation and characterization of tunicamycin.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2007.88

7 January 2021

Capuramycin, a new nucleoside antibiotic. Taxonomy, fermentation, isolation and characterization.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2007.88

7 January 2021

The structure of a new nucleoside antibiotic, capuramycin

1 reference

https://api.crossref.org/works/10.1038%2FJA.2007.88

7 January 2021

Studies on novel bacterial translocase I inhibitors, A-500359s. I. Taxonomy, fermentation, isolation, physico-chemical properties and structure elucidation of A-500359 A, C, D and G.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2007.88

7 January 2021

Studies on novel bacterial translocase I inhibitors, A-500359s. II. Biological activities of A-500359 A, C, D and G.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2007.88

7 January 2021

Studies on Novel Bacterial Translocase I Inhibitors, A-500359s. III. Deaminocaprolactam Derivatives of Capuramycin: A-500359 E, F, H, M-1 and M-2.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2007.88

7 January 2021

Studies on novel bacterial translocase I inhibitors, A-500359s. IV. Biosynthesis of A-500359s.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2007.88

7 January 2021

Studies on novel bacterial translocase I inhibitors, A-500359s. V. Enhanced production of capuramycin and A-500359 A in Streptomyces griseus SANK 60196.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2007.88

7 January 2021

Structures of the muraymycins, novel peptidoglycan biosynthesis inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FJA.2007.88

7 January 2021

Caprazamycin B, a novel anti-tuberculosis antibiotic, from Streptomyces sp.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2007.88

7 January 2021

Caprazamycins, novel lipo-nucleoside antibiotics, from Streptomyces sp. II. Structure elucidation of caprazamycins

1 reference

https://api.crossref.org/works/10.1038%2FJA.2007.88

7 January 2021

Pacidamycins, a novel series of antibiotics with anti-Pseudomonas aeruginosa activity. III. Microbiologic profile.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2007.88

7 January 2021

Susceptibility of Pseudomonas species to the novel antibiotics mureidomycins

1 reference

https://api.crossref.org/works/10.1038%2FJA.2007.88

7 January 2021

Methods for characterization of Streptomyces species

1 reference

https://api.crossref.org/works/10.1038%2FJA.2007.88

7 January 2021

Gradient selection in inverse heteronuclear correlation spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FJA.2007.88

7 January 2021

Synthetic dihydropacidamycin antibiotics: a modified spectrum of activity for the pacidamycin class

1 reference

https://api.crossref.org/works/10.1038%2FJA.2007.88

7 January 2021

Synthesis of sub-micromolar inhibitors of MraY by exploring the region originally occupied by the diazepanone ring in the liposidomycin structure

1 reference

https://api.crossref.org/works/10.1038%2FJA.2007.88

7 January 2021

Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin

1 reference

https://api.crossref.org/works/10.1038%2FJA.2007.88

7 January 2021

Synthesis and antimycobacterial activity of capuramycin analogues. Part 2: acylated derivatives of capuramycin-related compounds

1 reference

https://api.crossref.org/works/10.1038%2FJA.2007.88

7 January 2021

A-503083 A, B, E and F, novel inhibitors of bacterial translocase I, produced by Streptomyces sp. SANK 62799.

1 reference

https://api.crossref.org/works/10.1038%2FJA.2007.88

7 January 2021

Identifiers

DOI

10.1038/JA.2007.88

1 reference

26 December 2017

PubMed ID

18057698

1 reference

26 December 2017